It hasn’t been determined which day he will go against the Detroit Tigers, but it appears that Sergio Mitre will get a start. The 28 year old Mitre, who was 3-1, 2.40 ERA in seven starts with AAA Scranton, was a former starting pitcher for the Florida Marlins in 2006 when Joe Girardi was the manager.
Mitre had Tommy John surgery in July 2008 and had been rehabbing in the minors. He also had served a 50 game ban for ingesting andro, a supplement made famous by Mark McGwire.
Mitre is 10-26 with a 5.36 ERA in 78 major league games with the Marlins and Chicago Cubs.
Since Mitre is not on the Yankees 40-man roster, the Yankees would have to release somebody. The Yankees love to stockpile pitchers on their 40 man and I don’t see any pitcher, even Brett Tomko, getting let go.
So, with the emergence of Francisco Cervelli, and a plethora of young signal callers coming up through the Yankee ranks such as Jesus Montero, Austin Romine, Chase Weems and Kyle Higashioka, the released player will likely be AAA catcher Kevin Cash.
The Yankees use the catcher position like a wild card. They have at least three catchers at each level and move them around like chess pieces. Although it is a position where an extra veteran is always good, extra catchers like Cash are expendable, especially when the Yankees still have veteran Chris Stewart at AAA.
The 40 man change situation is probably why Alfredo Aceves started the one game in Minnesota last week. Not having Mitre start there gave the Yankees more time to decide who they would release from the 40 man roster.
The thing to look out for on Mitre is that he is a strike thrower, or as they say now, “he pounds the zone.” In his 45 AAA innings, he allowed only five walks whiles triking out 35. His peripheral numbers were a .241 BAA, K:BB of 7:1 and GO/FO ratio of 2.96.
Look for Mitre to go Sunday against the Tigers and Justin Verlander. If Mitre struggles, I hope that the Yankees do not pull starts away from Mtre. The Yankees need some stability in the rotation and Mitre is just as good, if not better, than anybodythey have available right now.